QUERCIS PHARMA AG

Lobbying client · filed 2026 to 2026

Manufacturing

$50,000 Reported spend

3 Filings counted

1 Outside firm hired

0 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page comes from one LDA client record (72971), filed by the registrant listed below.

Who filed for this client 1

COVENANT GOVERNMENT AFFAIRS, LLC $50,000 Outside firm · 3 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 1 year

2026 $50,000 3 filings

Issues lobbied 1

Manufacturing 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

Food & Drug Administration (FDA) 2
HOUSE OF REPRESENTATIVES 2
SENATE 2
Veterans Affairs, Dept of (VA) 2

Recent filings 3 total

Q3 report

COVENANT GOVERNMENT AFFAIRS, LLC

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 16, 2026

View → Q2 report

COVENANT GOVERNMENT AFFAIRS, LLC

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 9, 2026

View → Registration

COVENANT GOVERNMENT AFFAIRS, LLC

2nd Quarter 2026 (Apr 1 - June 30) · posted May 6, 2026

View →

Foreign entities disclosed 1

QUERCIS PHARMA AG Switzerland named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $10,000

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Keep going

Filings through October 16, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.